Horizon Pharma | HZNP - Ativo Circulante



Ativo Circulante Alterar Data
AbbVie USD 29.06B 523M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Coherus Biosciences USD 206.71M 254.25M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prestige Brands USD 433.43M 63.98M 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09
Zoetis USD 6.77B 185M 2025-12